Novel Drug Delivery Systems (NDDS) in Cancer Therapy Market to 2020: Trends, Business Strategies and Opportunities
The NDDS in cancer therapy market is categorized on the basis of technology into liquid embolics, nanoparticles, and embolization particles. Valued at US$3.3 bn in 2013, nanoparticles emerged as the leading technology segment in terms of revenue. This segment is projected to expand at an astounding 24.70% CAGR from 2014 to 2020, presenting the most promising opportunities for players within the NDDS in cancer therapy market. The segment of liquid embolics is forecast to expand at a 4.90% CAGR by...
View full press release